Popular Today
Popular Today
Popular All Time
Charts and Videos
Charts and Videos
17 0 1

I've been watching this one for a very little one waiting for some news. - News drop and bull pushed and found some resistance at 5c. - after over a week it looks to me as resistance has thinned out. I think we are on a new upward trend

dropme dropme BPMX, 15, Long ,
77 0 1
BPMX, 15 Long


StockGuild StockGuild CELZ, 1D, Long ,
144 2 2
CELZ, 1D Long
$CELZ Still Kicking Ass on the Way Up

$CELZ Remains unstoppable into the Mid May Bio Conference where they will be presenting, DD below in links.

StockGuild StockGuild CELZ, 1D, Long ,
225 4 1
CELZ, 1D Long
$CELZ Continues North with Accelerating Accumulation

$CELZ is currently on a clear and clean breakout in anticipation of the May 18th- 21st Presentation at the American Urological Association Convention in San Francisco. An 8K was released recently showing that shares were issued at .10 and as high as .30 levels The following link shows that the CEO has been buying on the way up as ...

StockGuild StockGuild CELZ, 1D, Long ,
66 0 2
CELZ, 1D Long
$CELZ Begins Breaking out on High buy Volume on News Release

$CELZ broke above prior high on the last leg after a release of 8-Ks showing the clearing up of the rest of the company's debt and notes. Item 1.01 Entry into a Material Definitive Agreement Effective April 11, 2018, Creative Medical Technology Holdings, Inc. (the “ Company ”) amended promissory notes issued by it and by its operating subsidiary, Creative ...

christiankat christiankat BSPM, 1M, Long ,
105 1 2
BSPM, 1M Long

$BSPM . You should see the big picture... ;-) (For studying purpose only.)

dvdgege5 dvdgege5 NTLA, D, Long ,
87 0 1
NTLA, D Long
NTLA - Inverse head & shoulders

An inverse head & shoulders pattern formed in the charts of Intellia, a company developing CRISPR gene-editing therapy. While CRISPR has not been approved to begin human trials in the US, it has already been tested on over 80 patients in China. Target: $31 (previous closing high), or long term hold Stop: $18 - $20

roosgar roosgar BIOS, 240, Long ,
83 0 5
BIOS, 240 Long
Trading ideas with BIOS

BIOS looks good for short term trading. It shows descending wedges at critical pivot points. Tweezers bottom reversal candles. Buy limit order at 2.45. Use a tight stop loss at 2.34. Take profits at 2.70 or 2.90. GL.

Cryptocol Cryptocol VDRM, 15, Long ,
36 0 0
VDRM, 15 Long
Exactly what we needed

Very pleased to see new life being breathed into this stock based on the news today Article - Fingers crossed for another big move upward next week. Gonna be a long weekend, have fun and stay safe

StockGuild StockGuild IDXG, 30, Long ,
71 0 4
IDXG, 30 Long
$IDXG On a Clear Breakout with Potential News Down Pipeline

$IDXG Latest Insider Purchases, Institutional Ownerships and News: 2016-02-03 Glorikian Harry Director Acquired 127,696 2016-02-03 KEEGAN JOSEPH D Director Acquired 127,696 2016-02-03 STOVER JACK E Interim President and CEO Director Acquired 294,756 2016-02-03 SULLIVAN STEPHEN J Director Acquired 295,656 2017-06-23 SC 13G ARMISTICE CAPITAL, LLC Acquired ...

37 0 3
BIOS Model

BIOS hit strong resistance at the 3.00 level and came off pretty hard. Beware, if it falls into the red triangle it could end up in the lower quadrant. However if it can get some traction and push through 3.02 it has plenty of upside imo

17 0 2
BIOS 6-28-17

BIOS setup with fibs 6-28-17

StockGuild StockGuild DCTH, 15, Long ,
365 0 5
DCTH, 15 Long
$DCTH Mid Term Goals could put this over $1+ In Weeks - Repost -

Reposting as it didn't post properly the first time $DCTH Highlights for the first quarter of 2017 and the recent weeks include: First quarter 2017 revenue of $0.74 million, an increase of 100% compared with revenue of $0.37 million in prior year quarter. CHEMOSAT treatment milestone set by SPIRE Southampton Hospital in the U.K. with more than 100 CHEMOSAT ...

PrezzNotSure PrezzNotSure ABBV, D, Long ,
50 0 3
ABBV, D Long
ABBV Breakout

Huge breakout for ABBV closing the day above the double top formed from 2014/2015 highs between 70.70 and 71.60, both offering little resistance. RSI pushing into the high 80s shows good strong move up in my opinion, I won't be using RSI for short/sell/TP signal, rather buy more when it dips to over-sold territory on consolidation in the next few weeks... if that ...

StockGuild StockGuild CTRV, D, Long ,
38 0 1
CTRV, D Long
$CTRV 1st Conference Starts Tmrw Continues in the Right Drtn

Nothing entirely new to report. Closed above last major resistance and still continues to stair step in the right direction. I think it should be noted and I didn't mention it before but the corporations who took a stake in the company in the last two months: Maxim Group set a $4.00 price target on shares of ContraVir Pharmaceuticals and gave the stock a “buy” ...

StockGuild StockGuild CTRV, D, Long ,
32 0 2
CTRV, D Long
$CTRV Continues to trend upwards Amid Bio Conferences

$CTRV announced today in addition to the 2017 Marcum MicroCap Conference 15-16 in New York, they will also be presenting at the San Diego Bio conference on June 19-22. Let's think about this hypothetically. If there was no news to present or bad news they wouldn't have more than one conference, I mean one conference would be more than enough to tell everything in ...

StockGuild StockGuild CTRV, D, Long ,
15 0 3
CTRV, D Long
$CTRV Runway Is Cleared for Take-Off

$CTRV to present at the 2017 Marcum MicroCap Conference being held June 15-16. 2017, at the Grand Hyatt New York in New York City .60s on this stock has always been a massive support level since 2014. Go back far enough and you can see where the stock hits .60 and then moves back to multi-dollars. This CEO doesn't do R/S's he is an old school OG who knows how to ...

StockGuild StockGuild CBIO, D, Long ,
34 0 3
CBIO, D Long
Newest Alert is $CBIO

$CBIO Recent Highlights and Upcoming Milestones Recent Highlights: Catalyst Biosciences’ Factor IX Recommended for Orphan Drug Designation in Europe Contract revenue for the three months ended March 31, 2017 was $0.3 million, compared with $0.1 million for the prior year period. The increase in contract revenue was due to the milestone revenue from ISU Abxis ...

Show More Ideas 123
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out